 Adaptive Biotechnologies Corporation NASDAQ:ADPT Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Karina Calzadilla - Vice President of Investor Relations Chad Robins - Chief Executive Officer and Co-Founder Kyle Piskel - Interim Chief Financial Officer Sharon Benzeno - Chief Commercial Officer, Immune Medicine Nitin Sood - Chief Commercial Officer, MRD Harlan Robins - Chief Scientific Officer Conference Call Participants Brian Weinstein - William Blair Elizabeth Webster - Goldman Sachs Mark Massaro - BTIG Derik de Bruin - Bank of America Disclaimer: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. 